This brand name is authorized in Nigeria.
The drug MARC-BLAST contains one active pharmaceutical ingredient (API):
1
|
Recombinant human epidermal growth factor
UNII
TZK30RF92W - NEPIDERMIN
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A6-100130 | Powder | Marc-Blast Lyophilized Powder PWD 70000 IU 70000IU | MARC-BLAST LYOPHILIZED POWDER. A6-100130 ( LYOPHILIZED POWDER. ) RECOMBINANT HUMAN BASIC FIBROBLAST GROWTH FACTOR FOR EXTERNAL USE ( rh-bFGF) 70000IU N/A 1X 70000IU/VIAL N/A MARCSON HEALTHCARE LIMITED LONGTIME BIOPHARMCEUTICL CO. LTD NANHAI HIHAN INFORMATION TECHNOLOGY PARK, FOSHAN CITY, GUANGDONG PROVINCE, P.R. CHINA 528200. 05/11/2023 30/10/2028 | 05/11/2023 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A6-100130 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.